Fort LP Boosted Its Gilead Sciences (GILD) Position by $1.75 Million; Valuation Declined; Lpl Financial Has Raised Holding in Intl Paper Co (IP) as Stock Declined

June 14, 2018 - By Ash

International Paper Company (NYSE:IP) Logo

Lpl Financial Llc increased its stake in Intl Paper Co (IP) by 9.35% based on its latest 2018Q1 regulatory filing with the SEC. Lpl Financial Llc bought 12,128 shares as the company’s stock declined 10.63% with the market. The institutional investor held 141,801 shares of the paper company at the end of 2018Q1, valued at $7.58M, up from 129,673 at the end of the previous reported quarter. Lpl Financial Llc who had been investing in Intl Paper Co for a number of months, seems to be bullish on the $23.54 billion market cap company. The stock decreased 0.63% or $0.36 during the last trading session, reaching $56.84. About 3.97 million shares traded or 40.00% up from the average. International Paper Company (NYSE:IP) has risen 3.78% since June 14, 2017 and is uptrending. It has underperformed by 8.79% the S&P500. Some Historical IP News: 04/05/2018 – SMURFIT KAPPA CEO REITERATES THAT INTERNATIONAL PAPER PROPOSAL ENTIRELY FAILS TO VALUE GROUP’S INTRINSIC BUSINESS WORTH, PROSPECTS; 06/03/2018 – Smurfit Kappa Rejects International Paper’s Offer (Correct); 06/03/2018 – Smurfit Kappa rejects International Paper bid approach; 23/03/2018 – International Paper: Board to Reduce to 12 Members After Annual Meeting; 23/05/2018 – Trio of Smurfit Kappa shareholders urge talks with International Paper -FT; 17/04/2018 – Feeding America® And International Paper Join Forces To Help People Facing Hunger And Recovering From Disasters; 26/03/2018 – SKG: Smurfit Kappa Group PLC: Statement re Rejection of Revised Proposal from International Paper; 06/03/2018 – International Paper Remains Ready to Engage with Smurfit Kappa; 26/03/2018 – SMURFIT BOARD UNANIMOUSLY REJECTS PROPOSAL FROM INTL PAPER; 16/05/2018 – IP CFO GLENN LANDAU SAYS AT INDUSTRY CONFERENCE IN NEW YORK

Michael Novogratz increased its stake in Gilead Sciences Inc (GILD) by 8.39% based on its latest 2018Q1 regulatory filing with the SEC. Fort Lp bought 23,333 shares as the company’s stock declined 17.62% with the market. The hedge fund run by Michael Novogratz held 301,368 shares of the health care company at the end of 2018Q1, valued at $22.72M, up from 278,035 at the end of the previous reported quarter. Fort Lp who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $92.51 billion market cap company. The stock increased 0.61% or $0.43 during the last trading session, reaching $71.15. About 4.51M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since June 14, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 26/03/2018 – Gilead’s Odefsey Rises After 1-Wk Fall, Descovy Advances: HIV; 21/05/2018 – ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV; 27/04/2018 – Gilead’s Biktarvy Gets Positive Recommendation in Europe; 12/03/2018 – Gilead Sciences Says Norbert Bischofberger to Step Dn as Chief Scientific Officer Effective at End Apri; 01/05/2018 – GILEAD EARNINGS CALL ENDS; 05/03/2018 – GILEAD SCIENCES INC – NO PATIENTS IN BIKTARVY TREATMENT ARM DEMONSTRATED TREATMENT-EMERGENT RESISTANCE THROUGH 48 WEEKS; 23/03/2018 – Gilead TAF Sales Rise 3%, HIV Combo Pills Gain 2%; 30/05/2018 – GILEAD, GALAPAGOS: EQUATOR ACHIEVES PRIMARY ENDPOINT OF ACR20; 23/03/2018 – Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine); 05/03/2018 – GLAXOSMITHKLINE STUDIED DOLUTEGRAVIR IN HIV, TUBERCULOSIS

Fort Lp, which manages about $349.60 million and $415.90 million US Long portfolio, decreased its stake in Herbalife Ltd (NYSE:HLF) by 29,796 shares to 34,497 shares, valued at $3.36M in 2018Q1, according to the filing. It also reduced its holding in Cvs Health Corp (NYSE:CVS) by 13,278 shares in the quarter, leaving it with 246,670 shares, and cut its stake in Ca Inc (NASDAQ:CA).

Investors sentiment increased to 0.88 in 2018 Q1. Its up 0.08, from 0.8 in 2017Q4. It is positive, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Cincinnati holds 938,419 shares. Adell Harriman Carpenter Inc has invested 0% in Gilead Sciences, Inc. (NASDAQ:GILD). First Commonwealth Corporation Pa has invested 0.77% in Gilead Sciences, Inc. (NASDAQ:GILD). C A S holds 278,870 shares or 0.32% of its portfolio. Aviva Public Ltd Co accumulated 777,220 shares. 131,600 were reported by Spark Invest Mngmt Ltd. 16,014 are owned by Charter Tru. Farallon Capital Management Ltd Limited Liability Company holds 0.95% or 1.82M shares. Fisher Asset Management Ltd Co reported 0.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Johnson Fincl Gru reported 48,702 shares or 0.44% of all its holdings. 106,114 are owned by Pillar Pacific Capital Mngmt Ltd Llc. Toth Fincl Advisory holds 0% or 137 shares. Health Value Cap Lc reported 100,000 shares or 31.33% of all its holdings. Wolverine Asset Mgmt Limited Com has invested 0% in Gilead Sciences, Inc. (NASDAQ:GILD). Ssi Inv Management owns 3,753 shares.

Among 31 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Gilead Sciences had 132 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Mizuho with “Buy” on Monday, February 5. The firm earned “Neutral” rating on Wednesday, February 8 by Citigroup. The rating was maintained by RBC Capital Markets on Monday, October 3 with “Outperform”. The firm earned “Buy” rating on Monday, July 24 by J.P. Morgan. The rating was maintained by Barclays Capital on Wednesday, May 2 with “Overweight”. The firm earned “Outperform” rating on Tuesday, January 16 by Wells Fargo. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Wednesday, February 7 by BMO Capital Markets. PiperJaffray reinitiated the stock with “Overweight” rating in Thursday, May 31 report. On Thursday, September 10 the stock rating was upgraded by Jyske Bank to “Strong Buy”. BMO Capital Markets maintained it with “Outperform” rating and $83 target in Friday, October 27 report.

Since January 2, 2018, it had 0 insider buys, and 23 selling transactions for $48.21 million activity. $440,741 worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Cogan John Francis. WILSON GAYLE E sold $4.68 million worth of stock or 60,000 shares. 5,000 shares were sold by Washington Robin L, worth $401,566. 14,435 shares were sold by Alton Gregg H, worth $1.18M. $8.02M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by Meyers James R.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead Sciences, Inc. (GILD) Presents at Goldman Sachs 39th Annual Global Healthcare Conference (Transcript)” on June 13, 2018, also Bizjournals.com with their article: “He helped Gilead score billions from HIV, hepatitis C drugs — now he’s building a cancer fighter” published on May 23, 2018, Seekingalpha.com published: “ContraVir on go to start clinical development of HBV candidate CRV431 in US; shares up 14% premarket” on June 14, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Globenewswire.com and their article: “Consolidated Research: 2018 Summary Expectations for Encana, Netflix, Veon, The Walt Disney, Gilead Sciences, and …” published on June 14, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead’s Evolution In Oncology, With Comments On Valuation” with publication date: June 07, 2018.

More news for International Paper Company (NYSE:IP) were recently published by: Seekingalpha.com, which released: “International Paper: Buy The Record Growth” on June 05, 2018. Fool.com‘s article titled: “Packaging Corp of America Takes the Line of Least Resistance” and published on June 14, 2018 is yet another important article.

Lpl Financial Llc, which manages about $36.33 billion US Long portfolio, decreased its stake in Powershares Etf Tr Ii (PWZ) by 101,542 shares to 301,106 shares, valued at $7.73M in 2018Q1, according to the filing. It also reduced its holding in Fqf Tr by 22,667 shares in the quarter, leaving it with 326,134 shares, and cut its stake in Amerisourcebergen Corp (Put) (NYSE:ABC).

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>